Boutoleau C, Guillon B, Martinez F, Vercelletto M, Faure A, Fève J R
Clinique Neurologique, Hôpital Laënnec, Centre Hospitalier Universitaire, Nantes, France.
Eur J Neurol. 2003 Sep;10(5):521-3. doi: 10.1046/j.1468-1331.2003.00632.x.
The first case of Creutzfeldt-Jakob disease (CJD) related to the use of a dura mater graft of cadaveric origin was identified in 1987 and this procedure is now considered as one of the main causes of iatrogenic CJD. Although the decontamination procedure for the preparation of graft material was modified, the product was withdrawn from the market in many countries a few years later and replaced by synthetic material. In this context, two patients treated in our institution developed CJD following a cadaveric dural graft performed after cerebral and lumbar trauma. Their clinical presentation, showing predominant cerebellar symptoms, late deterioration and myoclonic jerks, and a rapid disease course until death, was similar to that of previously reported cases involving the iatrogenic form. As the graft for one of the patients was performed in 1991 (several years after modification of the decontamination procedure), this fourth reported case suggests that the risk of iatrogenic CJD may have persisted in some patients treated after 1987, when grafts of cadaveric origin were totally abandoned.
1987年确认了首例与使用尸体来源硬脑膜移植相关的克雅氏病(CJD),目前该手术被视为医源性CJD的主要病因之一。尽管用于制备移植材料的去污程序有所改进,但几年后该产品在许多国家退市,并被合成材料所取代。在此背景下,我们机构治疗的两名患者在脑和腰椎创伤后接受尸体硬脑膜移植后患上了CJD。他们的临床表现以小脑症状为主、病情晚期恶化、出现肌阵挛抽搐,且疾病进展迅速直至死亡,与先前报道的医源性病例相似。由于其中一名患者的移植手术在1991年进行(去污程序改进后的数年),这第四例报告病例表明,1987年后一些接受治疗的患者可能仍存在医源性CJD风险,当时尸体来源的移植材料已被完全弃用。